Email Updates

Search form

You are here

8 MARCH 2019 VOLUME 20 ISSUE 9

Media Coverage

  • The top story from the Conference on Retroviruses and Opportunistic Infections (CROI 2019) in Seattle this week has been a likely second HIV cure. However, the cure involved an expensive and risky therapy – a bone-marrow transplant – that would never be broadly applicable.

    March 8, 2019
    aidsmap
  • A daily pill containing the newer formulation of tenofovir in combination with emtricitabine (Descovy) had a comparable protective effect to the existing daily pill which contains the older tenofovir and emtricitabine (Truvada), Dr Brad Hare of the Kaiser Permanente San Francisco Medical Center told the Conference on Retroviruses and Opportunistic Infections (CROI 2019) in Seattle today. As expected, the newer formulation had better bone and kidney safety outcomes.

    March 7, 2019
    aidsmap
  • Monthly shots of HIV drugs worked as well as daily pills to control the virus that causes AIDS in two large international tests, researchers reported Thursday.

    March 7, 2019
    Associated Press
  • Thirty-five percent of gay and bisexual men at high risk of HIV infection were using PrEP, or pre-exposure prophylaxis, the daily pill that prevents HIV infection, in 2017, according to data released Thursday by the Centers for Disease Control and Prevention. In 2014, just 6 percent of these men used PrEP.

    March 7, 2019
    NBC News
  • News the “London patient” has become the second-person ever found in remission of HIV has been hailed as a medical triumph, but new developments with pre-exposure prophylaxis, or PrEP, could mark additional steps in combatting the disease.

    March 6, 2019
    Washington Blade
  • With antimicrobial resistance at the top of the World Health Organization’s top 10 global health threats of 2019, it’s only natural that resistance is also at top of mind for those on the frontlines of the HIV epidemic.

    March 6, 2019
    Contagion Live
  • It is well known that HIV pre-exposure prophylaxis (PrEP) is effective in preventing HIV acquisition but, despite this fact, PrEP has not been widely prescribed to individuals who are at an increased risk of HIV exposure. When considering ways to increase the uptake of PrEP, a team of investigators hypothesized that using data from electronic health records (EHR) could be a method to identify patients who are at a higher risk for HIV and could benefit from PrEP.

    March 6, 2019
    Contagion Live
  • A man in London has been in remission from HIV for the past year and a half, making him the second known adult to be in remission and potentially cured of the infection.

    March 5, 2019
    Healthline
  • Testing everyone in a community for HIV and offering immediate treatment to all those who test positive can cut the number of new infections by around a third, according to new research.

    March 5, 2019
    General, Treatment
    Telegraph
  • When the England PrEP IMPACT Trial opened in October 2017, there was a tidal-wave of people rushing to get one of the 10,000 places on the Trial. Given this is the only current way of being able to get free PrEP through the NHS in England, it’s no surprise that many of the Trial’s clinics were full in under a year.

    March 5, 2019
    Gay Star News
  • Just over half (54.7 percent) of female sex workers in Zimbabwe reported being adherent to either condoms or pre-exposure prophylaxis (PrEP). But what are the factors influencing uptake of these two prevention interventions?

    March 5, 2019
    Avert
  • Thailand has achieved the first part of UNAIDS’ 90-90-90 targets: 98 percent of people infected with HIV know their status. Of that, 70 percent are receiving HIV treatment, and of them, 83 percent are virally suppressed. Thailand is on the right path to achieve HIV epidemic control, Praphan Phanuphak of the Thai Red Cross AIDS Research Center said as he delivered the N’Galy Mann Lecture, because the country has not shied away from taking risks in their HIV response and employing innovative methods to reach the most high-risk groups – lessons that could be applied in the U.S., he said.

    March 5, 2019
    General
    Science Speaks
  • For just the second time since the global epidemic began, a patient appears to have been cured of infection with HIV, the virus that causes AIDS.

    March 4, 2019
    New York Times
  • Since July 2012, the U.S. Food and Drug Administration has encouraged the daily use of Truvada as a HIV prevention strategy (i.e. PrEP). But these days, new strategies are emerging for those who’d rather not practice PrEP every day.

    March 4, 2019
    HIV Plus Mag
  • The combined use of pre-exposure prophylaxis (PrEP) and antiretroviral therapy (ART) can help HIV discordant couples have safe pregnancies, a new research shows.

    March 4, 2019
    Daily Nation
  • THE United States Agency for International Development (USAID) has given N$240 million towards a programme that seeks to reduce new HIV infections among adolescent girls and young women in Namibia.

    March 4, 2019
    General
    All Africa

Published Research

Announcements